GlassScriptPhysician profile
Anand Desai
NPI 1467986463
$1,669.90
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.43 · 2022: $692 · 2023: $909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.79 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $523.71 | 2021-2023 | Brilinta |
| Abbott Laboratories | $161.42 | 2023 | Aveir |
| E.R. Squibb & Sons, L.L.C. | $141.17 | 2022 | |
| Impulse Dynamics (USA) INC. | $131.61 | 2023 | Optimizer |
| Boston Scientific Corporation | $129.25 | 2023 | |
| Cardiva Medical, INC. | $126.48 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Shockwave Medical, INC | $125.10 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.55 | 2023 | Jardiance |
| Amgen INC. | $83.81 | 2023 | Repatha |
| Astellas Pharma US INC | $57.58 | 2021 | |
| Medtronic, INC. | $47.75 | 2023 | Corevalve Evolut R |
| Terumo Medical Corporation | $19.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anand Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.